Surveillance in inflammatory bowel disease: white light endoscopy with segmental re-inspection versus dye-based chromoendoscopy – a multi-arm randomised controlled trial (HELIOS)
HD white-light endoscopy with segmental re-inspection was non-inferior to HD chromoendoscopy for colorectal neoplasia detection in IBD patients. It can therefore be assumed that the benefit of HD chromoendoscopy may be explained by the longer withdrawal time and not necessarily the enhanced contrast. However, re-inspection per se did not lead to a significantly higher colorectal neoplasia rate than single-pass HD white-light endoscopy alone.
Authors
- Charlotte P. Peters (ORCID: https://orcid.org/0000-0001-6411-5438)
- Bas Oldenburg (ORCID: https://orcid.org/0000-0002-3962-6831)
- Anouk M. Wijnands (ORCID: https://orcid.org/0000-0003-1277-1796)
- Frank Hoentjen (ORCID: https://orcid.org/0000-0001-5314-4452)
- Andrea E. van der Meulen‐de Jong (ORCID: https://orcid.org/0000-0001-9353-5431)
- Maarten te Groen (ORCID: https://orcid.org/0000-0002-9323-1486)
- Philip W. Voorneveld (ORCID: https://orcid.org/0000-0002-3881-4435)
- Willemijn A. van Dop (ORCID: https://orcid.org/0000-0002-4653-6594)
- Dirk J. de Jong
- Marjolijn Duijvestein (ORCID: https://orcid.org/0000-0003-4814-9376)
- Nathan den Broeder (ORCID: https://orcid.org/0000-0001-7126-2209)
- Jeroen Maljaars (ORCID: https://orcid.org/0000-0003-0477-9499)
- Kimberly R. Boer
- Herma H. Fidder
- Meike M. Hirdes
- Fiona van Schaik
Institutions
- Radboud University Nijmegen (NL)
- University of Alberta (CA)
- Leiden University Medical Center (NL)
- Amsterdam UMC Location University of Amsterdam (NL)
- Radboud University Medical Center (NL)
- University Medical Center Utrecht (NL)
- Amsterdam University Medical Centers (NL)
- Vrije Universiteit Amsterdam (NL)
Publication Details
- Journal
- Gut
- Published
- 2025-01-16
- DOI
- https://doi.org/10.1136/gutjnl-2024-333446
- Citations
- 10
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 18.17
Funders
- Teva Pharmaceutical Industries